Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
01/2004
01/01/2004US20040002123 Detection of transmembrane potentials by optical methods
01/01/2004US20040001970 Organic electroluminescent materials and devices made from such materials
01/01/2004US20040001792 Decoloring hair and skin using ascorbic acid
12/2003
12/31/2003WO2004000827A1 Method for producing carbonyl compounds
12/31/2003WO2004000807A1 Cannabinoid receptor agonists
12/31/2003WO2004000796A1 Novel phthalamide derivatives
12/31/2003WO2004000793A2 Aminoacetonitrile derivatives suitable for controlling parasites
12/31/2003WO2004000783A1 Aminoalkylphenols, methods of using and making the same
12/31/2003WO2004000764A2 BENZO(b)FURAN DIMERS
12/31/2003WO2004000455A1 Titaniun-vanadium-tin comprising catalyst and process for the preparation of phthalic anhydride
12/31/2003WO2004000295A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003WO2003088959A3 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
12/31/2003WO2003059915A3 ENANTIOSELECTIVE METHODS FOR PREPARING α- AND β-AMINO ACID DERIVATIVES
12/31/2003CN1132828C O-substd. hydroxy coumaranone derivs as antineoplastic and antitransfer agent
12/31/2003CN1132827C 丁内酯的制备 Preparation butyrolactone
12/31/2003CN1132826C Process for preparing tetrahydrofuran by dewatering and cyclizing 1,4-butanediol
12/31/2003CN1132807C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
12/31/2003CN1132806C 蒸馏含丁二醇的混合物的方法 The method of distillation contains a mixture of butanediol
12/31/2003CN1132805C 制备γ－丁内酯、丁－1,4二醇和四氢呋喃的方法 Preparation of γ- butyrolactone, 1,4-diol Ding method and tetrahydrofuran
12/31/2003CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003CA2489842A1 Aminoacetonitrile derivatives suitable for controlling parasites
12/31/2003CA2489556A1 Titaniun-vanadium-tin comprising catalyst and process for the preparation of phthalic anhydride
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670507 Process for the preparation of aryloctanoyl amides
12/30/2003US6670487 Method for removing impurities from oxidation products
12/30/2003US6670445 Curable compounds, curable resin compositions containing the same and methods of easily disassembling cured materials
12/30/2003US6670358 Substituted thioacetamides
12/25/2003WO2003106461A2 Pseudopolymorphic forms of a hiv protease inhibitor
12/25/2003US20030236438 Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts
12/25/2003US20030236431 2-bromomethyl-6-methyl-benzoic acid and a process for the preparation thereof
12/25/2003US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones
12/25/2003US20030236294 Anticancer agents
12/25/2003US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
12/25/2003US20030236268 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
12/25/2003US20030236220 Mucin synthesis inhibitors
12/25/2003US20030236200 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
12/24/2003WO2003106446A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation
12/24/2003WO2003042135A3 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
12/24/2003WO2003039454A3 Beta-secretase inhibitors and methods of use
12/24/2003WO2003011846B1 Process for the preparation of 5-substituted isobenzofurans
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003CN1463266A Binaphthol derivative and method for producing same
12/24/2003CN1463264A Method for producing aromatic compound dimer
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CN1462747A High molecular monomer of chemical amplification type light resistance agent compson.
12/24/2003CN1131868C 作为药物的三环△3－哌啶 As a tricyclic drug △ 3- piperidine
12/24/2003CN1131859C 制备邻苯二甲酸酐的方法 The method of the production of phthalic anhydride
12/24/2003CN1131858C 旋光的氨基戊烷衍生物 Aminopentane optically active derivatives
12/24/2003CN1131857C Process for producing fatty acid esters of sorbitan as surfactants
12/24/2003CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667330 Cytoprotective; neuroinflammation and neurodegenerative disorders; oxidative stress related conditions
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667307 HIV protease
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/18/2003WO2003104209A1 Peptide deformylase inhibitors
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103660A1 Substituted phenylsulfonamide inhibitors of beta amyloid production
12/18/2003WO2003103599A2 Caspase-1 inhibitors and methods for their use
12/18/2003WO2003082192A3 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/18/2003WO2003045933A3 Preparation and use of gamma-butyrolactones as cross-linking agents
12/18/2003US20030232891 For therapy of pain
12/18/2003US20030232881 Large crystals suitable for use in direct compression
12/18/2003US20030232864 Novel Compounds and compositions as protease inhibitors
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232859 Antiinflammatory agents; for treatment of rheumatoid arthritis and multiple sclerosis
12/18/2003US20030232841 Amides such as 5-(2-(4-methylpiperazin-1-yl)-phenyl)-furan-2-carboxylic acid 4-chlorobenzylamide, used as antidepressants and for prophylaxis of headaches
12/18/2003US20030232824 Non-steroidal progesting
12/18/2003US20030232823 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof
12/18/2003US20030232811 Anthranilic acid derivative
12/18/2003US20030232809 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232807 Dietetic agents
12/18/2003US20030232802 Aryl and heteroaryl sulfonates
12/18/2003US20030232789 Salicylamides as serine protease and factor xa inhibitors
12/18/2003US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2486581A1 Substituted phenylsulfonamide inhibitors of beta amyloid production
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370545A1 Process for the preparation of citalopram
12/17/2003EP1370542A1 Bicyclic guanidine derivatives and therapeutic uses thereof
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370514A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
12/17/2003EP1370510A2 Hiv integrase inhibitors
12/17/2003EP1370139A2 Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof
12/17/2003EP1216237B1 Process for the preparation of mycophenolic acid and derivatives thereof
12/17/2003EP1109805B1 Inhibitors of bacterial nad synthetase
12/17/2003EP1109799B1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/17/2003EP1100775B1 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
12/17/2003EP1000047B1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring
12/17/2003EP0900212B1 Chiral phenyldihydrofuranones as pde-iv inhibitors
12/17/2003CN1131223C Process for producing trimellitic anhydride by continuous oxidizing process
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 472